High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples